Compare BIO & AUGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | AUGO |
|---|---|---|
| Founded | 1952 | 1946 |
| Country | United States | United States |
| Employees | 7450 | 1462 |
| Industry | Biotechnology: Laboratory Analytical Instruments | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 5.5B |
| IPO Year | N/A | N/A |
| Metric | BIO | AUGO |
|---|---|---|
| Price | $297.13 | $64.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $339.75 | $67.60 |
| AVG Volume (30 Days) | 353.3K | ★ 954.4K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.97% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.74 | $91.05 |
| Revenue Next Year | $3.20 | $17.09 |
| P/E Ratio | $9.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $236.73 | $23.55 |
| 52 Week High | $343.12 | $110.32 |
| Indicator | BIO | AUGO |
|---|---|---|
| Relative Strength Index (RSI) | 55.87 | 46.48 |
| Support Level | $293.88 | $59.30 |
| Resistance Level | $314.39 | $75.52 |
| Average True Range (ATR) | 9.70 | 3.86 |
| MACD | -0.59 | 0.75 |
| Stochastic Oscillator | 76.57 | 61.34 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Aura Minerals Inc is a mid-tier gold and copper production company focused on the development and operation of gold and base metal projects in the Americas. The company's operating segments include: Minosa Mine, Apoena Mine, the Aranzazu Mine, Almas Mine, Borborema Mine and Serra Grande Mine. It derives maximum revenue from Aranzazu Mine. The company's growth projects include: Matupa in Brazil, and Era Dorada in Guatemala. whereas its exploration projects include: Carajas, in Brazil, and Tolda Fria in Colombia.